172 related articles for article (PubMed ID: 8346930)
1. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
Hirashima Y; Shimura T; Tanaka Y; Demukai H; Kubota T; Kobayashi T; Suzuki A
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy in malignant gynecologic tumors using intraperitoneal catheter with a subcutaneous reservoir].
Shimizu A; Kimura T; Funatsu M; Hada Y; Araki H; Notake Y
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1795-9. PubMed ID: 1877820
[TBL] [Abstract][Full Text] [Related]
3. [Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors].
Shimizu A; Kimura T; Funatsu M; Hada Y; Tamura K; Taguchi A; Miyakawa Z; Notake Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1738-41. PubMed ID: 1530345
[TBL] [Abstract][Full Text] [Related]
4. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
Royer B; Delroeux D; Guardiola E; Combe M; Hoizey G; Montange D; Kantelip JP; Chauffert B; Heyd B; Pivot X
Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
[TBL] [Abstract][Full Text] [Related]
5. [Significance and effects of intraperitoneal cisplatin administration for ovarian cancer].
Shimizu A; Ookubo K; Hasegawa J; Endoh T; Fujiwara O; Yoda A; Okuyama D; Narabayashi A; Kimura T; Takahashi J; Notake Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1801-5. PubMed ID: 10560398
[TBL] [Abstract][Full Text] [Related]
6. [The pharmacokinetics of intraperitoneal (IP) carboplatin (CBDCA) and dose-up study of intravenous (IV) cyclophosphamide (CPM) in combination with IP CBCDA for advanced ovarian cancer patients].
Fujiwara K; Yamauchi H; Sawada S; Koike H; Mohri H; Ohishi Y; Kohno I
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2373-9. PubMed ID: 1463344
[TBL] [Abstract][Full Text] [Related]
7. [An aged patient with stage IV ovarian cancer successfully treated by intraperitoneal consecutive administration of cisplatin].
Narimatsu A; Okada O
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1225-9. PubMed ID: 9679588
[TBL] [Abstract][Full Text] [Related]
8. [The value of a Tenckhoff catheter in ovarian cancer].
Kato N; Arakawa A; Yasui Y; Suzumori K; Suzumori K; Yagami Y
Gan To Kagaku Ryoho; 1991 May; 18(6):1025-30. PubMed ID: 2029187
[TBL] [Abstract][Full Text] [Related]
9. [Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
Noda T; Adachi S; Yamamoto T; Hirooka C; Kiyozuka Y; Adachi S; Oku M; Ichijo M
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1561-8. PubMed ID: 2389949
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of carboplatin after intraperitoneal administration and clinical effect in ovarian cancer].
Ohno M; Hirokawa M; Hando T
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2355-61. PubMed ID: 1463342
[TBL] [Abstract][Full Text] [Related]
11. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
[TBL] [Abstract][Full Text] [Related]
12. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
Noda T; Oku M; Kiyozuka Y; Ninomiya Y; Hino K; Okamura Y; Maruyama M; Ichijo M
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1025-32. PubMed ID: 3566301
[TBL] [Abstract][Full Text] [Related]
13. [The effect of intraperitoneal and intra-aortic chemotherapy for unresectable gastric cancer].
Kawasaki S; Nagai K; Maruyama S; Murakami M; Yoshizane K; Morokoshi Y; Kawai K; Yamamoto M; Soda M
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2256-9. PubMed ID: 7944453
[TBL] [Abstract][Full Text] [Related]
14. [A case report: ovarian carcinoma IVth can become complete remission by immunochemotherapy].
Shimizu A; Hondoh T; Watanabe S; Moriyama S; Yoshida K; Miyakawa Z; Kimura T; Notake Y; Mitsuya T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2346-9. PubMed ID: 7944476
[TBL] [Abstract][Full Text] [Related]
15. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
Berry E; Matthews KS; Singh DK; Buttin BM; Lurain JR; Alvarez RD; Schink J
Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
[TBL] [Abstract][Full Text] [Related]
16. [Intraperitoneal chemotherapy of metastatic ovarian cancer].
Hasegawa E; Watanabe H; Ohmura G; Hirakawa S; Momose K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1742-4. PubMed ID: 1530346
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
Deng C; Huang R; Lian L
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
Gadducci A; Carnino F; Chiara S; Brunetti I; Tanganelli L; Romanini A; Bruzzone M; Conte PF
Gynecol Oncol; 2000 Feb; 76(2):157-62. PubMed ID: 10637064
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study.
Feun LG; Blessing JA; Major FJ; DiSaia PJ; Alvarez RD; Berek JS
Gynecol Oncol; 1998 Dec; 71(3):410-5. PubMed ID: 9887240
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.
Makhija S; Sabbatini P; Aghajanian C; Venkatraman E; Spriggs DR; Barakat R
Gynecol Oncol; 2000 Oct; 79(1):28-32. PubMed ID: 11006026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
